PPD DEVELOPMENT LP
- UEI
- ZANENSW6C665
- Land
- WILMINGTON (284013331)
- Gewonnen opdrachten
- 117
- Totale contractwaarde
- 78 844 754 USD
- Eerste opdracht
- 13/10/2017
- Laatste opdracht
- 19/09/2019
Gunningen (117)
| Datum | Aanbesteder | Omschrijving | Bedrag | Procedure |
|---|---|---|---|---|
| 19/09/2019 | Department of Health and Human Services - National Institutes of Health | R&D- MEDICAL: AIDS RESEARCH (BASIC RESEARCH) | 0 USD | COST PLUS AWARD FEE |
| 17/09/2019 | Department of Health and Human Services - National Institutes of Health | MODIFY TO EXERCISE OPTION 2 FOR YEAR 8 IN THE AMOUNT OF $410,386. | 410 386 USD | COST PLUS FIXED FEE |
| 16/09/2019 | Department of Defense - Department of the Army | BRAND NAMING SUPPORT | 0 USD | FIRM FIXED PRICE |
| 16/09/2019 | Department of Defense - Department of the Army | R&D - TOPICAL PAROMOMYCIN NDA | -131 438 USD | COST PLUS FIXED FEE |
| 12/09/2019 | Department of Health and Human Services - National Institutes of Health | PETRUKIN COST OVERRUN&REVISED SOW | 75 339 USD | COST PLUS FIXED FEE |
| 11/09/2019 | Department of Health and Human Services - National Institutes of Health | FY19 TRIAL EXECUTION OPTION ITEM #2 - KENNY-PHASE I SINGLE ASCENDING DOSE STUDY-BPN-19302 (AZD4041) PROTOCOL DEVELOPMENT AND FINALIZATION AND DATABASE BUILD AND BIOANALYTICAL METHODS DEVELOPMENT FOR C... | 1 184 807 USD | COST PLUS FIXED FEE |
| 10/09/2019 | Department of Health and Human Services - National Institutes of Health | MOD P00005: FAR CLAUSE 52.204-25 - ID/IQ PARENT AWARD FOR PHASE I CLINICAL TRIALS FOR DEVELOPMENT OF NEUROTHERAPEUTICS | 0 USD | COST PLUS FIXED FEE |
| 29/08/2019 | Department of Health and Human Services - National Institutes of Health | CANCER TRIALS SUPPORT UNIT (CTSU) | -1 213 USD | COST PLUS FIXED FEE |
| 27/08/2019 | Department of Defense - Department of the Army | ANALYSIS&INSPECTION - LABOR | -14 609 USD | FIRM FIXED PRICE |
| 22/08/2019 | Department of Defense - Department of the Army | BASE PERIOD FFP SERVICES - LABOR | -1 352 USD | FIRM FIXED PRICE |
| 22/08/2019 | Department of Health and Human Services - National Institutes of Health | POP: 09/28/2019-09/27/2020 CLINICAL SITE AND STUDY MONITORING FOR RESEARCH PARTNERSHIPS FOR GLOBAL MENTAL HEALTH. | 194 573 USD | LABOR HOURS |
| 15/08/2019 | Department of Health and Human Services - National Institutes of Health | TO PROVIDE MONITORING SERVICES FOR ONE (1) PHASE III CLINICAL TRIAL, A5300B/PHOENIX | 0 USD | COST PLUS FIXED FEE |
| 08/08/2019 | Department of Defense - Department of the Army | DEOBLIGATION OF EXCESS FUNDING ON EXPIRED CLINS AND OBLIGATION OF INCREMENTAL FUNDING ON ACTIVE CLINS. | 92 503 USD | FIRM FIXED PRICE |
| 25/07/2019 | Department of Health and Human Services - National Institutes of Health | PPD DEVELOPMENT LP:1106692 [18-007540]. MODIFICATION TO (1) CHANGE THE PERIOD OF PERFORMANCE; (2) ADD OPTIONAL TASKS TO THE STATEMENT OF WORK; AND (3) CHANGE THE TASK ORDER PRICE. | 78 400 USD | FIRM FIXED PRICE |
| 23/07/2019 | Department of Defense - Department of the Army | DEOBLIGATION OF EXCESS FUNDS IN SUPPORT OF MARKET ANALYSIS FOR MULTIPLEX BIOASSAY | -17 486 USD | FIRM FIXED PRICE |
| 16/07/2019 | Department of Health and Human Services - National Institutes of Health | TO PROVIDE MONITORING SERVICES FOR ONE (1) PHASE III CLINICAL TRIAL, A5300B/PHOENIX | 0 USD | COST PLUS FIXED FEE |
| 28/06/2019 | Department of Health and Human Services - National Institutes of Health | KENNY-PHASE I SINGLE ASCENDING DOSE STUDY-BPN-19302 (AZD4041) PROTOCOL DEVELOPMENT AND FINALIZATION AND DATABASE BUILD AND BIOANALYTICAL METHODS DEVELOPMENT FOR CLINICAL TRIAL EXECUTION | 269 989 USD | COST PLUS FIXED FEE |
| 28/06/2019 | Department of Health and Human Services - National Institutes of Health | BUCKPITT-PHASE I SINGLE ASCENDING DOSE STUDY-BPN-19186 (EC5026) PROTOCOL DEVELOPMENT AND FINALIZATION AND DATABASE BUILD AND BIOANALYTICAL METHODS DEVELOPMENT FOR CLINICAL TRIAL EXECUTION | 387 029 USD | COST PLUS FIXED FEE |
| 21/06/2019 | Department of Health and Human Services - National Institutes of Health | TO 1) EXERCISE OPTION 2 - YEAR 8, AND OBLIGATE $1,093,363 TO CONTRACT YEAR 8 AND 2) MODIFY ARTICLE B.2. ESTIMATED COST - OPTION TO REFLECT THE CHANGE. | 1 093 363 USD | COST PLUS FIXED FEE |
| 14/06/2019 | Department of Health and Human Services - National Institutes of Health | IGF::OT::IGF NIAID HIV AND OTHER INFECTIOUS DISEASES CLINICAL RESEARCH SUPPORT SERVICES (CRSS) | 9 017 561 USD | COST PLUS AWARD FEE |
Bekijk de officiele bron (DECP - data.economie.gouv.fr) (USAS)